• Wiley Online Library will be disrupted on 26 May from 10:00-12:00 BST (05:00-07:00 EDT) for essential maintenance

Wiley Handbook of Current and Emerging Drug Therapies

Wiley Handbook of Current and Emerging Drug Therapies

Online ISBN: 9780470041000

DOI: 10.1002/9780470041000

Browse by Table of Contents

  1. Major Issues in Pharmaceutical R & D
    1. Computational Chemistry: A Tool for Feeding R&D Pipelines
    2. Promising New Approaches for Discovering Ion-Channel Modulators
    3. Target-Based Approaches for Discovering Novel Oncology Drugs
    4. Can Biomarkers Increase R&D Productivity?
    5. Nanotechnology for Drug Discovery and Drug Design
    6. Progress in RNA-Based Therapeutics
    7. Advancing Drug Discovery Through Structure-Guided Drug Design
    8. Applications of Stem Cells in Drug Discovery
    9. Emerging Therapies to Treat Lupus Erythematosus
    10. Contrasting European and U.S. Patent Laws: Issues for the Pharmaceutical Industry
  2. Global Markets and National Policy
    1. Pharmaceutical Pricing and Reimbursement in Japan
    2. Pharmaceutical Pricing and Reimbursement in Canada
    3. The Impact of Reference Pricing in Europe
  3. Technological Advances and Business Opportunities
    1. Disease Management in the 21st Century
    2. The Trend Toward Personalized Medicine
    3. Metabolomics: The Next Omics Technology for the Diagnostics Industry
    4. HIV Diagnostics: Key Disease Management Role Spells Opportunity
    5. Sleep Disorders: Promotion and Awareness Will Drive Market Growth
    6. Tuberculosis: Trends, Challenges, and Opportunities in a Resurging Market
    7. Identifying Drug-Resistant Bacterial Infections: Opportunity and Activity in the Diagnostics Arena
  4. Infectious Diseases
    1. Human Immunodeficiency Virus (HIV)
  5. Introductory Chapters
    1. The Drug Discovery Process
    2. Clinical Trials, Overview
  6. Oncology
    1. Aggressive Non-Hodgkin's Lymphomas
    2. Bladder Cancer
    3. Breast Cancer
    4. Cervical Cancer
    5. Chronic Lymphocytic Leukemia (CLL)
    6. Chronic Myelogenous Leukemia
    7. Colorectal Cancer
    8. Malignant Melanoma
    9. Multiple Myeloma
    10. Non-Small-Cell Lung Cancer
    11. Ovarian Cancer
    12. Pancreatic Cancer
    13. Prostate Cancer
    14. Small-Cell Lung Cancer
  7. Immune System
    1. Allergic Rhinitis
    2. Asthma
    3. Crohn's Disease
    4. Psoriasis
    5. Rheumatoid Arthritis
  8. Metabolic Diseases
    1. Diabetic Retinopathy
    2. Dyslipidemia
    3. Metabolic Syndrome
    4. Obesity
    5. Osteoporosis
    6. Type 1 Diabetes
    7. Type 2 Diabetes
  9. Infectious Diseases
    1. Community-Acquired Pneumonia
    2. Complicated Skin and Soft Tissue Infections
    3. Acute Exacerbations of Chronic Bronchitis
    4. Hepatitis C
    5. Methicillin-Resistant Staphylococcus aureus
  10. Emerging Technologies and Business Opportunities
    1. Data and Information Integration in Pharmaceutical R&D
    2. Impact of Technological Advances on Pharmaceutical Productivity
    3. Advances in Medicinal Chemistry and Lead Optimization
    4. Biodefense Opportunities in the Biotechnology and Pharmaceutical Industries
    5. Fear of Theranostics: Why an Industry Has Not Really Emerged
    6. Beyond Commodity Drugs: Strategic Diversification in the Generics Industry
  11. Global Markets and National Policy
    1. The Indian Pharmaceutical Industry in Transition: Changes and Opportunities Ahead
    2. 43 Spotlight on the Australian and New Zealand Pharmaceutical and Biotechnology Industries
    3. Overview of the World's Major OTC Markets
    4. Biotech Hubs—Key Growth Engines for Drug Development
    5. Pharmaceutical Marketplace in Central and Eastern Europe
    6. Valuation Models for European Biotech
    7. Taking Global Action: Integrating Social Responsibility into Corporate Practices
    8. Global Branding Strategy: From the Blockbuster to the Targeted Model
  12. New Opportunities in Drug Discovery and Pipeline Development
    1. Prospects for Genomics—Derived Drugs: New Approaches and Impact on Pharmaceutical Pipelines
    2. Prying Open the Pipeline: Drug Discovery and Development in the Postgenomics Era
    3. Glycomics: The Impact of Carbohydrates on Biological Function and the Implications for Drug Discovery
    4. High-Content Screening for Drug Discovery and Target Validation
    5. High-Throughput ADMET Screening: Improving the Efficiency of Drug Discovery
    6. Emerging Concepts in GPCR Research and Their Implications for Drug Discovery
    7. Optimizing Knowledge Management in Pharmaceutical Companies
  13. Global Markets and National Policy
    1. The EU Clinical Trials Directive: Impact in Europe and Beyond
  14. Market Trends and Emerging Technologies
    1. Therapeutic Area Trends in R&D of the Top 20 Pharmaceutical Companies
  15. Central Nervous System
    1. Acute Ischemic Stroke
    2. Attention-Deficit/Hyperactivity Disorder
  16. Opthamologic
    1. Age-Related Macular Degeneration
  17. Cardiology
    1. Acute Heart Failure
  18. Central Nervous System
    1. Alzheimer's Disease
    2. Bipolar Disorder
  19. Genitourinary
    1. Benign Prostatic Hyperplasia
  20. Cardiology
    1. Chronic Heart Failure
  21. Pain Treatment
    1. Chronic Low Back Pain
  22. Respiratory
    1. Chronic Obstructive Pulmonary Disease
  23. Metabolic Diseases
    1. Diabetic Nephropathy
    2. Diabetic Neuropathy
  24. Cardiology
    1. Venous Thromboembolism
  25. Central Nervous System
    1. Epilepsy
  26. Pain Treatment
    1. Fibromyalgia
  27. Cardiology
    1. Hypertension
  28. Gastrointestinal
    1. Irritable Bowel Syndrome
  29. Central Nervous System
    1. Insomnia
    2. Major Depression
    3. Migraine Prophylaxis
    4. Mild Cognitive Impairment
    5. Minor Depression
    6. Multiple Sclerosis
  30. Cardiology
    1. Acute Coronary Syndrome: NSTEMI
    2. Peripheral Arterial Disease
  31. Central Nervous System
    1. Parkinson's Disease
  32. Cardiology
    1. Post-Myocardial Infarction
    2. Pulmonary Hypertension
  33. Central Nervous System
    1. Schizophrenia
  34. Genitourinary
    1. Stress Urinary Incontinence
    2. Urge Urinary Incontinence

SEARCH